CRISPR THERAPEUTICS AG

Ticker: CRSP CUSIP: H17182108 Class: NAMEN AKT

NewEdge Advisors, LLC's Holding History (CIK: 0001633516)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 3,558 Value ($000) $187 Avg Close $59.89 Range $48.02 - $78.48
Q3 2025
Shares 10,514 Value ($000) $681 Avg Close $57.41 Range $46.60 - $71.13
Q2 2025
Shares 8,577 Value ($000) $417 Avg Close $38.70 Range $30.04 - $51.52
Q1 2025
Shares 3,372 Value ($000) $115 Avg Close $42.39 Range $32.96 - $55.88
Q4 2024
Shares 7,420 Value ($000) $292 Avg Close $47.22 Range $38.20 - $59.07
Q3 2024
Shares 5,798 Value ($000) $272 Avg Close $50.74 Range $43.42 - $63.68
Q2 2024
Shares 9,523 Value ($000) $514 Avg Close $57.84 Range $51.02 - $68.39
Q1 2024
Shares 9,082 Value ($000) $619 Avg Close $71.59 Range $58.29 - $91.10
Q4 2023
Shares 1,972 Value ($000) $123 Avg Close $55.02 Range $37.55 - $76.97
Q3 2023
Shares 1,309 Value ($000) $59 Avg Close $51.65 Range $44.53 - $59.67
Q2 2023
Shares 1,339 Value ($000) $75 Avg Close $56.74 Range $43.10 - $72.00
Q1 2023
Shares 2,033 Value ($000) $92 Avg Close $48.57 Range $39.88 - $58.50
Q4 2022
Shares 12,730 Value ($000) $405 Avg Close $53.05 Range $38.94 - $66.31
Q3 2022
Shares 15,140 Value ($000) $989 Avg Close $72.47 Range $60.41 - $86.95